Orgenesis Inc (QX) (ORGS) 뉴스

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Form 8-K - Current report

Form 8-K - Current report

Dr. David Sidransky Appointed to Orgenesis' Board of Directors

TEL AVIV, Israel and WHITE PLAINS, N.Y., July 18, 2013 (GLOBE NEWSWIRE) -- Orgenesis Inc. (OTCBB:ORGS) ("Orgenesis" or the "Company"), a...

Orgenesis to Present Updates at Two Key June Conferences

TEL AVIV, Israel and WHITE PLAINS, N.Y., May 30, 2013 (GLOBE NEWSWIRE) -- Orgenesis Inc. (OTCBB:ORGS) ("Orgenesis" or the "Company"), a...

Orgenesis and ATMI Enter Into Process Development Agreement

TEL AVIV, Israel and WHITE PLAINS, N.Y., May 9, 2013 (GLOBE NEWSWIRE) -- Orgenesis Inc. (OTCBB:ORGS) ("Orgenesis" or the "Company"), a...

Leading Diabetes Expert, Jay S. Skyler, M.D., Joins Orgenesis' Scientific Advisory Board

TEL AVIV, Israel and WHITE PLAINS, N.Y., April 11, 2013 (GLOBE NEWSWIRE) -- Orgenesis Inc. (OTCBB:ORGS) ("Orgenesis" or the "Company"), a...

Orgenesis to Present at ATTD 2013

TEL AVIV, Israel and WHITE PLAINS, N.Y., Feb. 20, 2013 (GLOBE NEWSWIRE) -- Orgenesis Inc. (OTCBB:ORGS) ("Orgenesis" or the "Company"), a...

Orgenesis Announces Management Changes

WHITE PLAINS, N.Y., Jan. 7, 2013 (GLOBE NEWSWIRE) -- Orgenesis Inc. (OTCBB:ORGS) ("Orgenesis" or the "Company"), a development-stage company with...

Orgenesis Appoints Leading Diabetes Expert, Camillo Ricordi, M.D., to Scientific Advisory Board

Orgenesis Inc. (OTCBB:ORGS) (“Orgenesis” or the “Company”), a development-stage company with a novel therapeutic technology...